Cocrystal Pharma (COCP) Short-term Investments (2017 - 2026)

Cocrystal Pharma has reported Short-term Investments for 10 years, with the latest figure at $75000.0 in Q1 2026.

• Quarterly Short-term Investments changed 0.0% year-over-year to $75000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $75000.0, changed 0.0% from the prior year.
• Short-term Investments was little changed at $75000.0 in Q1 2026 per COCP's latest filing, from $75000.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $75000.0 in Q2 2022 and troughed at $75000.0 in Q2 2022.
• A 5-year average of $75000.0 and a median of $75000.0 in 2022 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments soared 50.0% in 2022, then changed 0.0% in 2023.
• Over 5 years, Short-term Investments stood at $75000.0 in 2022, then changed by 0.0% to $75000.0 in 2023, then changed by 0.0% to $75000.0 in 2024, then changed by 0.0% to $75000.0 in 2025, then changed by 0.0% to $75000.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $75000.0, $75000.0, and $75000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.